Home/Filings/4/0001144204-19-002703
4//SEC Filing

Bendheim Daniel M 4

Accession 0001144204-19-002703

CIK 0001069899other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 9:04 PM ET

Size

21.7 KB

Accession

0001144204-19-002703

Insider Transaction Report

Form 4
Period: 2019-01-22
Bendheim Daniel M
DirectorExec. VP, Corporate Strategy
Transactions
  • Exercise/Conversion

    Option to purchase Common Stock

    2019-01-242,5009,780 total
    Exercise: $11.83From: 2014-03-01Exp: 2019-02-28Class A Common Stock (2,500 underlying)
  • Sale

    Class A Common Stock

    2019-01-23$31.58/sh1,910$60,318590 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2019-01-222,50014,780 total
    Exercise: $11.83From: 2013-03-01Exp: 2019-02-28Class A Common Stock (2,500 underlying)
  • Exercise/Conversion

    Option to purchase Common Stock

    2019-01-232,50012,280 total
    Exercise: $11.83From: 2013-03-01Exp: 2019-02-28Class A Common Stock (2,500 underlying)
  • Sale

    Class A Common Stock

    2019-01-22$31.40/sh2,500$78,5000 total
  • Exercise/Conversion

    Class A Common Stock

    2019-01-22$11.83/sh+2,500$29,5752,500 total
  • Exercise/Conversion

    Class A Common Stock

    2019-01-23$11.83/sh+2,500$29,5752,500 total
  • Exercise/Conversion

    Class A Common Stock

    2019-01-24$11.83/sh+2,500$29,5752,500 total
  • Sale

    Class A Common Stock

    2019-01-23$32.18/sh590$18,9860 total
  • Sale

    Class A Common Stock

    2019-01-24$31.78/sh2,500$79,4500 total
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.82, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.07, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.13 to $32.21, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.10, inclusive.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeother

Related Parties

1
  • filerCIK 0001601576

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 9:04 PM ET
Size
21.7 KB